APA (7th ed.) Citation

Deng, L., Ren, J., Li, B., Wang, Y., Jiang, N., Wang, Y., & Cui, H. (2023). Predictive value of CCL2 in the prognosis and immunotherapy response of glioblastoma multiforme. BMC Genomics, 24(1), 1. https://doi.org/10.1186/s12864-023-09674-x

Chicago Style (17th ed.) Citation

Deng, Longfei, Jie Ren, Benqin Li, Yinggang Wang, Nianfen Jiang, Yi Wang, and Hongjuan Cui. "Predictive Value of CCL2 in the Prognosis and Immunotherapy Response of Glioblastoma Multiforme." BMC Genomics 24, no. 1 (2023): 1. https://doi.org/10.1186/s12864-023-09674-x.

MLA (9th ed.) Citation

Deng, Longfei, et al. "Predictive Value of CCL2 in the Prognosis and Immunotherapy Response of Glioblastoma Multiforme." BMC Genomics, vol. 24, no. 1, 2023, p. 1, https://doi.org/10.1186/s12864-023-09674-x.